ArticlePloS one2020

Semicarbazide-sensitive amine oxidase inhibition ameliorates albuminuria and glomerulosclerosis but does not improve tubulointerstitial fibrosis in diabetic nephropathy.

May Yw Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.